Home > Insider Trading > Filing (0001104659-19-037461)

Filing Details

Accession Number:: 0001104659-19-037461
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-25 18:06:07
Reporting Period:: 2019-06-24

Accepted Time:: 2019-06-25 18:06:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1744659	Akero Therapeutics Inc.	AKRO	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1708269	Atlas Venture Fund Xi, L.p.	400 Technology Sq. 10Th Floor Cambridge MA 02139	No	No	Yes	No
1759241	Atlas Venture Opportunity Fund I, L.p.	400 Technology Sq. 10Th Floor Cambridge MA 02139	No	No	Yes	No
1780065	Atlas Venture Associates Opportunity I, L.p.	400 Technology Sq. 10Th Floor Cambridge MA 02139	No	No	Yes	No
1780066	Atlas Venture Associates Opportunity I, Llc	400 Technology Sq. 10Th Floor Cambridge MA 02139	No	No	Yes	No
1780067	Atlas Venture Associates Xi, Llc	400 Technology Sq. 10Th Floor Cambridge MA 02139	No	No	Yes	No
1780068	Atlas Venture Associates Xi, L.p.	400 Technology Sq. 10Th Floor Cambridge MA 02139	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-06-24	3,469,759	$0.00	3,469,759	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2019-06-24	235,099	$0.00	235,099	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2019-06-24	270,000	$16.00	505,099	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-06-24	10,666,667	$0.00	3,469,759	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-06-24	722,737	$0.00	235,099	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Represents the total number of shares of common stock received by Atlas Venture Fund XI, L.P. ("AVF XI") upon the conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
All series of preferred stock automatically converted into the Issuer's common stock on a 3.07418-for-one basis upon the closing of the Issuer's initial public offering on June 24, 2019 and had no expiration date.
Represents the total number of shares of common stock received by Atlas Opportunity Fund I, L.P. ("AVO I") upon the conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
These shares are owned directly by AVF XI. Atlas Venture Associates XI, L.P., ("AVA XI LP") is the general partner of AVF XI. Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVF XI LP. Each of AVA XI LP and AVA XI LLC disclaims Section 16 beneficial ownership of the securities held by AVF XI, except to the extent of its pecuniary interest therein, if any.
These shares are owned directly by AVO I. Atlas Venture Associates Opportunity I, L.P. ("AVAO LP") is the general partner of AVO I. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. Each of AVAO LP and AVAO LLC disclaims Section 16 beneficial ownership of the securities held by AVO I, except to the extent of its pecuniary interest therein, if any.
On June 24, 2019, AVO I purchased 270,000 shares of common stock of the Issuer at a price of $16.00 per share pursuant to an underwritten public offering.